NDC 76420-024
Eszopiclone 2 mg tablet, film coated
On the label: Asclemed USA, Inc.. It's repackaged: Asclemed USA, Inc. rebottles it from Macleods Pharmaceuticals Limited's NDC 33342-300.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | District Solan, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyOct 20, 2023 · 6 inspections, 2 with FDA action |
Repackaging site
- Asclemed USA Inc. dba Enovachem, Torrance, CA, United States · repackages it and relabels it
Recalls
- Jun 16, 2022 · Class II · Macleods Pharma Usa Inc
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Lots: Lot #: BEK2009A Exp: 11/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Eszopiclone: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 2 mg
- Approval
- ANDA ANDA202929
- On the market since
- Jan 31, 2015
- Package NDCs
76420-024-0176420-024-1076420-024-2076420-024-3076420-024-6076420-024-90- Official label
- DailyMed (National Library of Medicine), updated Feb 12, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?